Skip to content

Effect of Flaxseed on Lipid Uptake and Appetite

Effect of Whole Flaxseeds and Flaxseed Mucilage on Lipid Absorption, Glucose and Insulin Metabolism and Appetite Regulation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00465036
Enrollment
18
Registered
2007-04-24
Start date
2006-10-31
Completion date
2007-10-31
Last updated
2009-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

fat absorption, fibres

Brief summary

Randomized trial to test the effect of flaxseed fractions on appetite regulation and intestinal lipid absorption.

Detailed description

Randomized multiple crossover trial in 18 healthy males aged 18 to 40 years each are required to complete a total of five iso-caloric meal tests lasting approximately 8½ hours. Test meals will be given as breakfast meals, in which different fractions of flaxseeds are incorporated into baked products. Appetite will be registered using visual analogue scales during 7 hours after the test meal and a total of 10 blood samples will be drawn to evaluate TAG in chylomicrons, plasma LDL, HDL and total cholesterol, plasma TAG, insulin, glucose and appetite hormone levels. At the end of the test day an ad libitum meal will be served and food intake registered.

Interventions

DIETARY_SUPPLEMENTWhole flaxseeds, flaxseed mucilage, glucomannan

Sponsors

University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy males aged 18-40 years * Normal weight or moderately overweigh (BMI 25-30 kg/m2)

Exclusion criteria

* Blood drawing/donation less than six months prior to start of the study * Hemoglobin concentration \<8mmol/L * Chronic diseases (i.e. diabetes, CVD), hypertension, hyperlipidemia * Consumption of dietary supplements including vitamin tablets * Smoking * Excess physical activity (\>10h of intense physical activity per week) * Medicine use (not including occasional consumption of pain killers)

Design outcomes

Primary

MeasureTime frame
appetite hormone levels
TAG in chylomicrons
serum TAG
HDL, LDL and total cholesterol
appetite scores
ad libium food intake

Secondary

MeasureTime frame
free fatty acid profile
plasma glucose
plasma insulin
meal macronutrient composition
meal energy content
meal pleasantness

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026